Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Email me when HR 10133 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HR 10133. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The legislation would amend the Public Health Service Act, ERISA, and the Internal Revenue Code so that any cost‑sharing requirement for a prescription drug cannot be higher than the nationwide average price paid by consumers. It would affect health‑insurance plans, employers offering coverage, and individuals who pay out‑of‑pocket for medicines. The goal is to prevent unusually high copays or coinsurance that exceed what most consumers actually pay.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HR 10133
3 free questions a day, no accountSponsors
- Rep. Scholten, Hillary J. [D-MI-3] (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HR 10133 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 10133 freeOr ask your AI assistant about HR 10133 directly:
Add to Claude, ChatGPT or Cursor